Trials / Completed
CompletedNCT03194555
The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination
Randomized, Double-Blind, Study to Assess Low-Dose Naltrexone and Acetaminophen Combination in the Prevention of Episodic Migraine in Adults
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Allodynic Therapeutics, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Preventive Treatment of Migraine with Low-Dose Naltrexone and Acetaminophen Combination: A Small, Randomized, Double-Blind, and Placebo-Controlled Clinical Trial with an Open-Label Extension for None-Responders
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Low-Dose Naltrexone and Acetaminophen Combination | Twice daily |
| DRUG | Placebo | Twice daily |
Timeline
- Start date
- 2017-08-25
- Primary completion
- 2018-07-26
- Completion
- 2018-07-28
- First posted
- 2017-06-21
- Last updated
- 2024-04-10
- Results posted
- 2024-04-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03194555. Inclusion in this directory is not an endorsement.